Phorbol myristate induces apoptosis of taxol-resistant sarcoma cells in vitro

European Journal of Pharmacology

Volumn 489, Issue 1-2, 2004, Pages 3-11

  Zong, Zhi Ping ^a   Matsui, Shinobu ^a   Katsuda, Shogo ^a   Han, Jian Feng ^a   Fujikawa Yamamoto, Kohzaburo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bcl 2; PMA; Polyploidization; Taxol resistant cell

Indexed keywords

CASPASE; PACLITAXEL; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BCL 2; PROTEIN KINASE C ACTIVATOR; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; FLOW CYTOMETRY; MALE; MOUSE; MULTIDRUG RESISTANCE; MULTIGENE FAMILY; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SARCOMA CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASES; CELL CYCLE; CELL LINE, TUMOR; DNA; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; GENES, BCL-2; GENES, P53; MALE; MICE; MICE, INBRED BALB C; MITOSIS; ONCOGENE PROTEIN P21(RAS); PACLITAXEL; POLYPLOIDY; S PHASE; SARCOMA, EXPERIMENTAL; SURVIVAL; TETRADECANOYLPHORBOL ACETATE;

EID: 1942484442     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.02.027     Document Type: Article

References (48)

1. Arnal I., Wade R.H. How does taxol stabilize microtubules? Curr. Biol. 5:1995;900-908.
2. Bhalla K., Huang Y., Tang C., Self S., Ray S., Mahoney M.E., Ponnathpur V., Tourkina E., Ibrado A.M., Bullock G. Characterization of a human myeloid leukemia cell line highly resistant to taxol. Leukemia. 8:1994;465-475.
3. Cabral F., Abraham I., Gottesman M.M. Isolation of a taxol-resistant Chinese hamster ovary cell mutant that has an alteration in alpha-tubulin. Proc. Natl. Acad. Sci. U. S. A. 78:1981;4388-4391.
4. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257:1982;7847-7851.
5. Chang F., Syrjanen S., Tervahauta A., Syrjanen K. Tumourigenesis associated with the p53 tumour suppressor gene. Br. J. Cancer. 68:1993;653-661.
6. Chang J.C., Wooten E.C., Tsimelzon A., Hilsenbeck S.G., Gutierrez M.C., Elledge R., Mohsin S., Osborne C.K., Chamness G.C., Allred D.C., O'Connell P. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet. 362:2003;362-369.
7. Chuang T.C., Lee Y.J., Liu J.Y., Lin Y.S., Li J.W., Wang V., Law S.L., Kao M.C. EBNA1 may prolong G(2)/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs. Biochem. Biophys. Res. Commun. 307:2003;653-659.
8. Colamonici O.R., Trepe J.B., Vidal C.A., Neckers L.M. Phorbol ester induces c-sis gene transcription in stem cell line K-562. Mol. Cell. Biol. 6:1986;1847-1850.
9. Del Bino G., Bruno S., Yi P.N., Darzynkiewicz Z. Apoptotic cell death triggered by camptothecin or teniposide: the cell cycle specificity and effects of ionizing radiation. Cell Prolif. 25:1992;537-548.
10. Duan Z., Feller A.J., Toh H.C., Makastorsis T., Seiden M.V. TRAG-3, a novel gene, isolated from a taxol-resistant ovarian carcinoma cell line. Gene. 229:1999;75-81.
11. Fujimura S., Suzumiya J., Yamada Y., Kuroki M., Ono J. Downregulation of Bcl-x(L) and activation of caspases during retinoic acid-induced apoptosis in an adult T-cell leukemia cell line. Hematol. J. 4:2003;328-335.
12. Gabriel B., Sureau F., Casselyn M., Teissie J., Petit P.X. Retroactive pathway involving mitochondria in electroloaded cytochrome c-induced apoptosis. Protective properties of Bcl-2 and Bcl-(XL). Exp. Cell Res. 289:2003;195-210.
13. Goncalves A., Braguer D., Kamath K., Martello L., Briand C., Horwitz S., Wilson L., Jordan M.A. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc. Natl. Acad. Sci. U. S. A. 98:2001;11737-11742.
14. Hartwig J.H., Thelen M., Rosen A., Janmey P.A., Nairn A.C., Aderem A. MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature. 356:1992;618-622.
15. Haupt S., Berger M., Goldberg Z., Haupt Y. Apoptosis - the p53 network. J. Cell. Sci. 116:2003;4077-4085.
16. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
17. Ikizawa K., Kajiwara K., Basaki Y., Koshio T., Yanagihara Y. Evidence for a role of phosphatidylinositol 3-kinase in IL-4-induced germline C epsilon transcription. Cell. Immunol. 170:1996;134-140.
18. Jacobson M.D., Burne J.F., King M.P., Miyashita T., Reed J.C., Raff M.C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature. 361:1993;365-369.
19. Kavallaris M., Burkhart C.A., Horwitz S.B. Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol. Br. J. Cancer. 80:1999;1020-1025.
20. Kuhn D.J., Smith D.M., Pross S., Whiteside T.L., Dou Q.P. Overexpression of interleukin-2 receptor alpha in a human squamous cell carcinoma of the head and neck cell line is associated with increased proliferation, drug resistance, and transforming ability. J. Cell. Biochem. 9:2003;824-836.
21. Le X.F., Hittelman W.N., Liu J., Mc Watters A., Li C., Mills G.B., Bast R.C. Jr. Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosis. Oncogene. 22:2003;484-497.
22. Ling Y.H., Consoli U., Tornos C., Andreeff M., Perez-Soler R. Accumulation of cyclin B1, activation of cyclin B1-dependent kinase and induction of programmed cell death in human epidermoid carcinoma KB cells treated with taxol. Int. J. Cancer. 75:1998;925-932.
23. Martello L.A., Verdier-Pinard P., Shen H.J., He L., Torres K., Orr G.A., Horwitz S.B. Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation. Cancer Res. 63:2003;1207-1213.
24. Narvaez C.J., Byrne B.M., Romu S., Valrance M., Welsh J. Induction of apoptosis by 1,25-dihydroxyvitamin D3 in MCF-7 vitamin D3-resistant variant can be sensitized by TPA. J. Steroid Biochem. Mol. Biol. 84:2003;199-209.
25. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 233:1986;305-312.
26. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-614.
27. O'Brien M.E., Splinter T., Smit E.F., Biesma B., Krzakowski M., Tjan-Heijnen V.C., Van Bochove A., Stigt J., Smid-Geirnaerdt M.J., Debruyne C., Legrand C., Giaccone G. Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study. Eur. J. Cancer. 39:2003;1416-1422.
28. Parmar M.K., Ledermann J.A., Colombo N., du Bois A., Delaloye J.F., Kristensen G.B., Wheeler S., Swart A.M., Qian W., Torri V., Floriani I., Jayson G., Lamont A., Trope C. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet. 361:2003;2099-2106.
29. Posner M.R., Lefebvre J.L. Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck. Br. J. Cancer. 88:2003;11-17.
30. Rellamy C.O.C., Clarke A.R., Wyllie A.H. p53 deficiency in liver reduces local control of survival and proliferation, but dose not affect apoptosis after DNA damage. FASEB J. 11:1997;591-599.
31. Rosengurt E., Rodriquez-Pena A., Coombs M., Sinnet-Smith J. Diacylglycerol stimulates DNA synthesis and cell division in mouse 3T3 cells: role of Ca2+-sensitive phospholipid-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 81:1984;5748-5752.
32. Roy S.N., Horwitz S.B. A phosphoglycoprotein associated with taxol resistance in J774.2 cells. Cancer Res. 45:1985;3856-3863.
33. Sibley D.R., Lefkowitz R.J. Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model. Nature. 317:1985;124-129.
34. Singh K.R., Taylor L.K., Campbell X.Z., Fields A.P., Neet K.E. A bryostatin-sensitive protein kinase C required for nerve growth factor activity. Biochemistry. 33:1994;542-551.
35. Solit D.B., Basso A.D., Olshen A.B., Scher H.I., Rosen N. Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol. Cancer Res. 63:2003;2139-2144.
36. Torres K., Horwitz S.B. Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res. 58:1998;3620-3626.
37. Waga S., Hannon G.J., Beach D., Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369:1994;574-578.
38. Wang T.H., Wang H.S., Ichijo H., Giannakakou P., Foster J.S., Fojo T., Wimalasena J. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem. 273:1998;4928-4936.
39. Wang S., Guo C.Y., Castillo A., Dent P., Grant S. Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937). Biochem. Pharmacol. 56:1998;635-644.
40. Wani M.C., Taylor H.L., Wall M.E., Coggon P., McPhail A.T. Plant antitumor agents: VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93:1971;2325-2327.
41. Wei W., Nurse P., Broek D. Yeast cells can enter a quiescent state through G1, S, G2, or M phase of the cell cycle. Cancer Res. 53:1993;1867-1870.
42. Yamashita S., Mita S., Kato S., Okado H., Ohama E., Uchino M. Bcl-2 expression using retrograde transport of adenoviral vectors inhibits cytochrome c-release and caspase-1 activation in motor neurons of mutant superoxide dismutase 1 (G93A) transgenic mice. Neurosci. Lett. 350:2003;17-20.
43. Yoshida M., Heike Y., Ohno S., Ikekawa T., Wakasugi H. Involvement of PKC betaII in anti-proliferating action of a new antitumor compound gnidimacrin. Int. J. Cancer. 105:2003;601-606.
44. Yu D., Liu B., Jing T., Sun D., Price J.E., Singletary S.E., Ibrahim N., Hortobagyi G.N., Hung M.C. Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol. Oncogene. 16:1998;2087-2094.
45. Yusuf R.Z., Duan Z., Lamendola D.E., Penson R.T., Seiden M.V. Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation. Curr. Cancer Drug Targets. 3:2003;1-19.
46. Zhou J., Cheng S.C., Luo D., Xie Y. Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line. Biochem. Biophys. Res. Commun. 280:2001;1237-1242.
47. Zong Z.P., Fujikawa-Yamamoto K., Li A.L., Yamaguchi N., Chang Y.G., Murakami M., Odashima S., Ishikawa Y. Both low and high concentrations of staurosporine induce G1 arrest through down-regulation of cyclin E and cdk2 expression. Cell Struct. Funct. 24:1999;457-463.
48. Zong Z.P., Fujikawa-Yamamoto K., Li A.L., Yamaguchi N., Chang Y.G., Murakami M., Ishikawa Y. Involvement of protein kinase C in taxol-induced polyploidization in a cultured sarcoma cell line. Eur. J. Pharmacol. 394:2000;181-187.